• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏组织工程:多种方法及潜在应用

Cardiac tissue engineering: Multiple approaches and potential applications.

作者信息

Gisone Ilaria, Cecchettini Antonella, Ceccherini Elisa, Persiani Elisa, Morales Maria Aurora, Vozzi Federico

机构信息

Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

出版信息

Front Bioeng Biotechnol. 2022 Oct 3;10:980393. doi: 10.3389/fbioe.2022.980393. eCollection 2022.

DOI:10.3389/fbioe.2022.980393
PMID:36263357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9574555/
Abstract

The overall increase in cardiovascular diseases and, specifically, the ever-rising exposure to cardiotoxic compounds has greatly increased animal testing; however, mainly due to ethical concerns related to experimental animal models, there is a strong interest in new models focused on the human heart. In recent years, human pluripotent stem cells-derived cardiomyocytes (hiPSC-CMs) emerged as reference cell systems for cardiac studies due to their biological similarity to primary CMs, the flexibility in cell culture protocols, and the capability to be amplified several times. Furthermore, the ability to be genetically reprogrammed makes patient-derived hiPSCs, a source for studies on personalized medicine. In this mini-review, the different models used for cardiac studies will be described, and their pros and cons analyzed to help researchers choose the best fitting model for their studies. Particular attention will be paid to hiPSC-CMs and three-dimensional (3D) systems since they can mimic the cytoarchitecture of the human heart, reproducing its morphological, biochemical, and mechanical features. The advantages of 3D heart models compared to traditional 2D cell cultures will be discussed, and the differences between scaffold-free and scaffold-based systems will also be spotlighted.

摘要

心血管疾病的总体增加,尤其是对心脏毒性化合物的暴露不断上升,极大地增加了动物实验;然而,主要由于与实验动物模型相关的伦理问题,人们对专注于人类心脏的新模型有着浓厚的兴趣。近年来,人多能干细胞衍生的心肌细胞(hiPSC-CMs)因其与原代心肌细胞的生物学相似性、细胞培养方案的灵活性以及能够多次扩增的能力,成为心脏研究的参考细胞系统。此外,基因重编程的能力使患者来源的hiPSC成为个性化医学研究的一个来源。在本综述中,将描述用于心脏研究的不同模型,并分析其优缺点,以帮助研究人员为其研究选择最合适的模型。将特别关注hiPSC-CMs和三维(3D)系统,因为它们可以模拟人类心脏的细胞结构,再现其形态、生化和机械特征。将讨论3D心脏模型相对于传统2D细胞培养的优势,也将突出无支架和基于支架的系统之间的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3807/9574555/84b12bd89e41/fbioe-10-980393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3807/9574555/84b12bd89e41/fbioe-10-980393-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3807/9574555/84b12bd89e41/fbioe-10-980393-g001.jpg

相似文献

1
Cardiac tissue engineering: Multiple approaches and potential applications.心脏组织工程:多种方法及潜在应用
Front Bioeng Biotechnol. 2022 Oct 3;10:980393. doi: 10.3389/fbioe.2022.980393. eCollection 2022.
2
Scaffold-based and scaffold-free cardiac constructs for drug testing.基于支架和无支架的心脏构建体用于药物测试。
Biofabrication. 2021 Jul 22;13(4). doi: 10.1088/1758-5090/ac1257.
3
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
4
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.二维和三维培养体系中人诱导多能干细胞衍生心肌细胞在心血管疾病建模中的应用。
Int J Mol Sci. 2020 May 11;21(9):3404. doi: 10.3390/ijms21093404.
5
Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening.诱导多能干细胞衍生的心肌细胞用于心血管疾病建模和药物筛选。
Stem Cell Res Ther. 2013 Dec 24;4(6):150. doi: 10.1186/scrt380.
6
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform.在微流控平台中开发 3D 有序的人心肌组织。
J Vis Exp. 2021 Jun 15(172). doi: 10.3791/62539.
7
Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.开发合适的脂肪酸配方以提高构建心肌组织的收缩性。
Regen Ther. 2022 Sep 29;21:413-423. doi: 10.1016/j.reth.2022.09.006. eCollection 2022 Dec.
8
Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).基于人诱导多能干细胞分化的心肌细胞(hiPSC-CMs)的慢性心脏毒性检测。
Int J Mol Sci. 2022 Mar 16;23(6):3199. doi: 10.3390/ijms23063199.
9
Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.心力衰竭患者诱导多能干细胞的诱导与心肌细胞分化。
Eur Heart J. 2013 Jun;34(21):1575-86. doi: 10.1093/eurheartj/ehs096. Epub 2012 May 22.
10
Construction of 3D cardiac tissue with synchronous powerful beating using human cardiomyocytes from human iPS cells prepared by a convenient differentiation method.使用方便的分化方法从人诱导多能干细胞制备的人心肌细胞构建具有同步强力搏动的 3D 心脏组织。
J Biosci Bioeng. 2020 Jun;129(6):749-755. doi: 10.1016/j.jbiosc.2020.01.001. Epub 2020 Mar 6.

引用本文的文献

1
Integration of co-culture conditions and 3D gelatin methacryloyl hydrogels to improve human-induced pluripotent stem cells-derived cardiomyocytes maturation.整合共培养条件和3D甲基丙烯酰化明胶水凝胶以改善人诱导多能干细胞衍生心肌细胞的成熟。
Front Bioeng Biotechnol. 2025 Jul 14;13:1576824. doi: 10.3389/fbioe.2025.1576824. eCollection 2025.
2
Three-Dimensional Visualization of the Cardiac Stroma.心脏基质的三维可视化
Cells. 2025 Jul 21;14(14):1119. doi: 10.3390/cells14141119.
3
Cardiac organoids: a new tool for disease modeling and drug screening applications.

本文引用的文献

1
Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype.系统转录组学和表型特征分析人类和鼠心肌细胞系及原代心肌细胞,揭示了其与成年人心肌表型存在严重局限性和低相似度。
J Mol Cell Cardiol. 2022 Apr;165:19-30. doi: 10.1016/j.yjmcc.2021.12.007. Epub 2021 Dec 24.
2
Human Organs-on-Chips: A Review of the State-of-the-Art, Current Prospects, and Future Challenges.人体芯片器官:技术现状、当前前景及未来挑战综述
Adv Biol (Weinh). 2022 Jan;6(1):e2000526. doi: 10.1002/adbi.202000526. Epub 2021 Nov 27.
3
心脏类器官:疾病建模和药物筛选应用的新工具。
Front Cardiovasc Med. 2025 May 20;12:1537730. doi: 10.3389/fcvm.2025.1537730. eCollection 2025.
4
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
5
Hydrogels for Cardiac Tissue Regeneration: Current and Future Developments.用于心脏组织再生的水凝胶:现状与未来发展
Int J Mol Sci. 2025 Mar 5;26(5):2309. doi: 10.3390/ijms26052309.
6
Advances in cardiac organoid research: implications for cardiovascular disease treatment.心脏类器官研究进展:对心血管疾病治疗的意义
Cardiovasc Diabetol. 2025 Jan 18;24(1):25. doi: 10.1186/s12933-025-02598-8.
7
Multicellular 3D models to study myocardial ischemia-reperfusion injury.用于研究心肌缺血再灌注损伤的多细胞3D模型。
Front Cell Dev Biol. 2024 Nov 15;12:1494911. doi: 10.3389/fcell.2024.1494911. eCollection 2024.
8
Development of Novel 3D Spheroids for Discrete Subaortic Stenosis.用于离散性主动脉瓣下狭窄的新型3D球体的研发。
Cardiovasc Eng Technol. 2024 Dec;15(6):704-715. doi: 10.1007/s13239-024-00746-x. Epub 2024 Nov 4.
9
Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery.诱导多能干细胞衍生构建型心脏组织用于疾病建模和治疗发现的研究进展。
Cells. 2024 Jan 29;13(3):250. doi: 10.3390/cells13030250.
10
Recent advances in biological pumps as a building block for bioartificial hearts.作为生物人工心脏组成部分的生物泵的最新进展。
Front Bioeng Biotechnol. 2023 Jan 20;11:1061622. doi: 10.3389/fbioe.2023.1061622. eCollection 2023.
Magnetic 3D cell culture: State of the art and current advances.
磁性3D细胞培养:现状与当前进展。
Life Sci. 2021 Dec 1;286:120028. doi: 10.1016/j.lfs.2021.120028. Epub 2021 Oct 7.
4
3D models of dilated cardiomyopathy: Shaping the chemical, physical and topographical properties of biomaterials to mimic the cardiac extracellular matrix.扩张型心肌病的3D模型:塑造生物材料的化学、物理和拓扑特性以模拟心脏细胞外基质。
Bioact Mater. 2021 Jun 10;7:275-291. doi: 10.1016/j.bioactmat.2021.05.040. eCollection 2022 Jan.
5
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues.使用人类 3D 心脏微组织的致心律失常性毒性的预测性体外风险评估平台。
Sci Rep. 2021 May 13;11(1):10228. doi: 10.1038/s41598-021-89478-9.
6
Layer-By-Layer Fabrication of Large and Thick Human Cardiac Muscle Patch Constructs With Superior Electrophysiological Properties.具有卓越电生理特性的大型厚层人类心肌补片构建体的逐层制造
Front Cell Dev Biol. 2021 Apr 16;9:670504. doi: 10.3389/fcell.2021.670504. eCollection 2021.
7
Reconstructing the heart using iPSCs: Engineering strategies and applications.使用 iPS 细胞重建心脏:工程策略与应用。
J Mol Cell Cardiol. 2021 Aug;157:56-65. doi: 10.1016/j.yjmcc.2021.04.006. Epub 2021 Apr 22.
8
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells.从人类多能干细胞中生成、功能分析和应用同基因三维自聚集心脏微组织。
Nat Protoc. 2021 Apr;16(4):2213-2256. doi: 10.1038/s41596-021-00497-2. Epub 2021 Mar 26.
9
Development of a drug screening system using three-dimensional cardiac tissues containing multiple cell types.利用包含多种细胞类型的三维心脏组织开发药物筛选系统。
Sci Rep. 2021 Mar 11;11(1):5654. doi: 10.1038/s41598-021-85261-y.
10
Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.人诱导多能干细胞衍生的心肌细胞、3D心脏结构和芯片心脏作为药物研究工具。
Pflugers Arch. 2021 Jul;473(7):1061-1085. doi: 10.1007/s00424-021-02536-z. Epub 2021 Feb 24.